COMMUNIQUÉS West-GlobeNewswire

Galapagos Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
23/02/2026
Strategic reset positions Galapagos for long-term value creation Robust 2025 year-end cash and financial investments of €3.0 billion and ongoing collaboration with Gilead enable flexibility to execute on a business [...]
Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study
23/02/2026
Dallas, TX, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform [...]
Pixel Health Launches One Thread™, an AI-Powered Experience Layer for Unified Patient Access and Engagement
23/02/2026
A collaborative go-to-market approach with Praia Health that accelerates digital front door transformation while keeping health systems in control of their strategy and brand. HOLYOKE, Mass., Feb. 23, 2026 (GLOBE [...]
Enspire Dental Marks Full Transition to Woman-Owned Private Practice Amid Rising Cosmetic Dentistry Demand in Ann Arbor
23/02/2026
Patients increasingly seek cosmetic dentistry, blending confidence with oral health at Enspire Dental. Ann Arbor, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Enspire Dental, a family and general dentistry practice in Ann Arbor, [...]
Foundation for Sarcoidosis Research Receives 2025 RareVoice Award for Federal Advocacy During Rare Disease Month
23/02/2026
CHICAGO, Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) has been named a 2025 RareVoice Awards recipient by EveryLife Foundation for Rare Diseases , earning national recognition for [...]
RESTEM to Present at BIO Investment & Growth Summit 2026
23/02/2026
MIAMI, Feb. 23, 2026 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that CEO, [...]
Andrzej Lewandowski of Dempster Therapeutic Services Receives Prestigious 2026 ZocDoc Patient Choice Award
23/02/2026
Chicago, IL, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Dempster Therapeutic Services is proud to announce that Andrzej Lewandowski , Speech-Language Pathologist and founder, has been honored with the 2026 ZocDoc Patient Choice [...]
IBA – ACQUISITION OF OWN SHARES
23/02/2026
Louvain-la-Neuve, Belgium, February 23 rd , 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA [...]
IBA – ACQUISITION D’ACTIONS PROPRES
23/02/2026
Louvain-la-Neuve, Belgique, 23 février 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") [...]
EssilorLuxottica: Disclosure of transactions in own shares
23/02/2026
Disclosure of transactions in own shares Paris, France (February 23, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2025, EssilorLuxottica declares that [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
23/02/2026
Déclaration de transactions sur actions propres Paris, France (23 février 2026, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2025, EssilorLuxottica déclare que du 16 février 2026 [...]
Cylinder Health and Stonebrook Risk Solutions announce strategic partnership to strengthen digestive disease management
23/02/2026
The collaboration expands Stonebrook’s specialty ecosystem with a virtual-first digestive health center of excellence delivering coordinated care across the full spectrum of GI conditions CHICAGO, Feb. 23, 2026 (GLOBE [...]
MedWell Ai Reports Strong Q2 Revenues Of $548,315 And Provides Guidance For Full Year 2025 Exceeding $2,200,000
23/02/2026
CLEARWATER, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) -- via IBN -- MedWell Ai, Inc, (OTCQB: MWAI ) ("Company") is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals, healthcare, and [...]
Liposoma Technology Strengthens Its Position as a Reference Partner for Advanced Lipid-Based Delivery Systems in Europe
23/02/2026
Bridging the Gap Between Scientific Innovation and Scalable Industrial Manufacturing Amsterdam, NORTH HOLLAND, Feb. 23, 2026 (GLOBE NEWSWIRE) -- A science-driven platform supports premium nutraceuticals, medical [...]
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
23/02/2026
LONDON and NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
Seismic Therapeutic to Participate in Upcoming Investor Conferences
23/02/2026
WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Seismic Therapeutic, Inc. , the machine learning immunology company, today announced that company management will participate in the following investor conferences: TD [...]
Aligos Therapeutics Presents Positive Data at the Conference on Retroviruses and Opportunistic Infections (CROI)
23/02/2026
SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies [...]
Cerevance to Participate in the TD Cowen 46th Annual Health Care Conference
23/02/2026
BOSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing targeted therapies for neurodegenerative diseases and obesity, today announced participation in one-on-one [...]
Artios Receives U.S. FDA Fast Track Designation for DNA Polymerase Theta (Polθ) Inhibitor ART6043 for Treatment of gBRCA-mutated HER2-Negative Breast Cancer
23/02/2026
U.S. Fast Track designation of ART6043 underpinned by promising clinical data to date and high unmet need in gBRCA-mutated HER2-negative breast cancer Artios is launching a global randomized Phase 2 study to evaluate [...]

Pages